This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company based in Madison, Wisconsin. The contract, valued at $79,736.40, is for the delivery of a LUCIFERASE 1000 ASSAY (AMBIS #1676428) product from Promega. This award does not utilize any set-aside designation. Promega is a major supplier of specialized laboratory equipment,...
This is a firm-fixed-price contract award by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company based in Madison, Wisconsin. The contract is for the purchase of the BRIGHT-GLO Luciferase Assay System, a product used in biological research and molecular diagnostics. The award ceiling value is $6,579.00. This is a Blanket Purchase Agreement (BPA) call, which is a type of...
This is a $13,289.40 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation for the purchase of luciferase reagents. The contract has an ultimate completion date of April 11, 2014 and does not utilize any set-aside designations. Promega Corporation is a global life sciences company that provides a wide range of products and services to support biomedical...
This is a $17,981.60 firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Promega Corporation, a global manufacturer of life science research products, for a 10-pack of Luciferase Assay System kits. The order was placed under a larger $11.5 million BPA Promega holds with the Defense Health Agency for DNA analysis systems, forensic reagents, and related laboratory products. This contract does not utilize any...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company. The $18,240.40 contract is for the procurement of 40 units of the E1501 Luciferase Assay System, a specialized laboratory product used in biological research and testing. This award is part of a larger $11.5 million BPA that Promega holds with the...
The U.S. Department of Health and Human Services (HHS) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5,805.80 firm-fixed-price purchase order to Promega Corporation, a global life sciences company, for a luminometer system. The award did not utilize any set-aside designations. Promega has provided a range of specialized laboratory equipment, reagents, and services to support biomedical research and testing programs across various federal agencies, including the NIH,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company based in Madison, Wisconsin. The award, valued at $19,874.40, is for the procurement of 26 units of the LUCIFERASE 1000 REAGENT, Catalog # E4550, at $382.20 per unit. This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order with a completion date of March 8, 2012....
This is a $23,119.20 firm fixed price Blanket Purchase Agreement (BPA) call by the National Institute of Allergy and Infectious Diseases (NIAID) under the National Institutes of Health (NIH) to Promega Corporation, a global life sciences company, for the procurement of 45 units of the Luciferase Assay System 10-pack. The contract has no set-aside designation. Promega is the prime contractor and there are no major subcontractors mentioned. The Luciferase Assay System is a specialized laboratory...
This federal contract award, valued at $3,451.95, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Promega Corporation, a global life sciences company headquartered in Madison, Wisconsin. The award is for the purchase of CellTiter-Glo Luminescent Cell Viability Assay reagents, which are used for biological research, molecular diagnostics, and forensic analysis. Promega has supplied a range of specialized laboratory...
This federal contract award to Promega Corporation, doing business as Promega Corp, is a Blanket Purchase Agreement (BPA) call with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $49,686 contract is for the procurement of 65 units of the Luciferase 1000 Reagent, Cat# E4550, at $382.20 per unit. This contract does not utilize a small business set-aside. Promega is a large, for-profit manufacturer of life sciences...